What motivates people to lose weight? This is an important topic. At @Ro, we’re constantly speaking to our patients to understand their goals and their reasons for joining our Body Program. Check out some of that data and what it says about men and women’s motivations for seeking

Lived experiences always foster the most needed innovation.

When 776 portco Ro Founder + CEO Z Reitano witnessed the impact GLP1s had on his dad’s health, he knew Ro could scale access to the kind of obesity care his dad experienced.

The Ro team got to work 😤 🔥

Our CEO, Z Reitano, emphasized the profound impact that anti-obesity medications could have on the healthcare system and beyond. Tune into his conversation w/ Bob Safian on the Masters of Scale podcast.

Our CEO, Z Reitano joined Katie Greifeld and David Westin on Bloomberg TV to discuss the unprecedented demand for anti-obesity medications and why so many patients are choosing to get care through Ro. youtube.com/watch?v=dzerYS…

Weight loss drugs took health care by storm in 2023 🩺 Ro CEO Z Reitano walks us through the increased demand he's seeing for obesity treatments and how his platform uses telehealth to oversee prescriptions for eligible patients.

Our CEO, Z Reitano joined Sara Eisen and Frank Holland on CNBC's Money Movers today to talk about the rapid growth of the GLP-1 market and Ro’s plans for 2024. Watch here: cnbc.com/video/2023/12/… #obesitycare #telehealth #chroniccare

GLP1s are inevitable. Delaying coverage can be the single largest accelerant of health inequity in our lifetime and increasing it the most powerful tool to bridge the gap.

ro.co/weight-loss/gl…

'I felt like I at least had an advocate for me.' Ro fights for patients like Stephanie every day, navigating the complexities of insurance so they don't have to. Watch to hear more about Stephanie's experience with the Body Program on Good Morning America: goodmorningamerica.com/wellness/video…

Food For Thought: The Potential Ripple Effect of GLP1s. Hope it’s as interesting to read as it was to write.

ro.co/weight-loss/po…

Excited to share that Ro's CEO, Z Reitano has joined the Tech:NYC Board, an expanded group of 60 top tech leaders in New York. We’re glad to support this incredible network, which is committed to the long-term success of New York City. bit.ly/3RlFKKu

Ro'ers have always been passionate about fighting for patients, and the current shortage is no exception. Despite the shortage being beyond Ro's control, our team is taking full ownership of the issue and implementing measures to support patients. Read more:

A lot of people have asked me recently about “Ozempic Face”. What is it? Is it real? In fact, it reminds me a lot of “Bicycle Face”...

A thread:

It’s time to fight weight bias and stigma. That’s why we partnered with OAC to survey people with obesity nationwide to learn about their weight loss motivations, experiences, and interest in GLP-1s. ro.co/weight-loss/ob…

'Ro helps patients achieve their health care goals in the most effective and convenient way,' Ro CEO Z Reitano says. 'We've done that by seamlessly integrating a doctor's office, pharmacy, and lab.' Full comments:

Ro’s CEO, Z Reitano, dives into why new, highly effective GLP-1 medications spark such passionate—and often difficult—discussions as well as the research and data behind the most common questions about obesity and GLP-1s. ro.co/weight-loss/ac…

Our ads are starting the exact conversation that we think is vital to have for patients. For decades, society has viewed obesity differently than other chronic diseases and the reaction continues to reaffirm this. We’re glad that conversation is happening. wsj.com/articles/hype-…

Our new ads aim to start an important conversation about de-stigmatizing obesity as a chronic condition and educating people about incredibly effective treatment that may be a solution for millions of people with weight & metabolic health goals. medium.com/ro-co/why-were…

'This is what I love about direct-to-patient healthcare. We form relationships with our patients — if we don’t serve them, we go out of business,” Ro's Z Reitano shared at #WSJHealth . Watch here: wsj.com/video/events/w…

“Patients with obesity, whether they are family, friends, or a celebrity we see on television, deserve access to this incredible tool.” Read Fast Company to learn why Ro believes it’s time to end weight bias and transform care for the millions living with obesity.